Related Experiment Video
Updated: Mar 15, 2026

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
Development of risperidone liposomes for brain targeting through intranasal route
Reema Narayan1, Mohan Singh1, OmPrakash Ranjan2
1Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India 576104.
Functionalized risperidone liposomes were developed for nasal delivery to treat schizophrenia. Optimized PEGylated liposomes demonstrated enhanced brain targeting and increased drug uptake, showing potential for effective brain delivery.
Area of Science:
- Pharmaceutical Sciences
- Nanotechnology
- Neuroscience
Background:
- Schizophrenia management requires effective drug delivery to the brain.
- Traditional delivery methods face challenges in crossing the blood-brain barrier.
- Liposomes offer a promising platform for targeted drug delivery.
Purpose of the Study:
- To develop functionalized risperidone liposomes for enhanced brain targeting via nasal administration.
- To optimize liposome formulation for improved entrapment efficiency and reduced vesicle size.
- To evaluate the in vivo efficacy and brain targeting potential of the developed liposomes.
Main Methods:
- Liposomes were prepared using the thin film hydration method and optimized with Design-Expert® Software.
- Liposome surfaces were modified with stearylamine and MPEG-DSPE for enhanced brain penetration.
- Formulations were characterized for vesicle size, zeta potential, entrapment efficiency, and morphology (TEM).
- In vivo pharmacokinetic studies in Wistar albino rats were conducted following intranasal administration.
Main Results:
- Optimized liposomes exhibited a mean vesicle size of 90-100nm with high entrapment efficiency (50-60%).
- Transmission Electron Microscopy confirmed spherical vesicles with a smooth surface.
- Functionalized liposomes, particularly PEGylated ones (LP-16), showed prolonged drug release and significantly enhanced brain exposure compared to plasma.
- LP-16 demonstrated a high brain targeting efficiency index, indicating preferential brain transport.
Conclusions:
- Surface-modified risperidone liposomes were successfully formulated for nasal delivery.
- PEGylated liposomes show significant potential for targeted delivery of risperidone to the brain for schizophrenia treatment.
- This approach offers a promising strategy for improving the therapeutic management of neurological disorders.
More Related Videos
05:28A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System
Published on: August 15, 2019
05:50Intranasal Delivery of mRNA Polyplexes via Rayleigh Breakup Aerosols: An In Vitro Method for Nasal Deposition and Functional Testing
Published on: January 20, 2026
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bioavailability Enhancement: Drug Permeability Enhancement
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Delivery: Enteral Route